TrumpRx website for discounted drugs launches
NEW YORK (AP) — The Trump administration on Thursday launched TrumpRx, a website it says will help patients…
Hims and Hers Health’s compounded Wegovy pill offering fuels market jitters
Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Novo’s Wegovy pill hits 18,410 US prescriptions in encouraging debut week
By Sriparna Roy Jan 23 (Reuters) – Novo Nordisk’s Wegovy pill was prescribed 18,410 times in the U.S.…
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever
Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio…
Alabama saw its highest ever economic development in 2025, Ivey says
Alabama in 2025 announced 234 economic development projects totaling $14.6 billion, the highest annual total ever, with 9,388…
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process.…
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
Credit: Chai Discovery | Image Credits:Chai Discovery Drug discovery, the art of identifying new molecules to develop pharmaceuticals,…
Which Is the Better Stock Buy?
Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified…
FDA commissioner’s drug review plan sparks alarm
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
Takeaways on turmoil surrounding FDA fast-track drug program
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…